The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
L
|
Lumentum Holdings Inc
SWB:LU2
|
US |
|
Berkshire Hathaway Inc
MIL:1BRK
|
US |
|
I
|
Instone Real Estate Group SE
DUS:INS
|
DE |
|
I
|
Instone Real Estate Group SE
XMUN:INS
|
DE |
|
SIG Group AG
SIX:SIGN
|
CH |
|
Instone Real Estate Group SE
F:INS
|
DE |
|
Severn Trent PLC
F:SVT
|
UK |
|
Aena SME SA
OTC:ANYYY
|
ES |
|
E
|
Eurofins Scientific SE
DUS:ESF0
|
LU |
|
Cementir Holding NV
F:3PC
|
IT |
|
O
|
O'Reilly Automotive Inc
SWB:OM6
|
US |
|
N
|
Naga Dhunseri Group Ltd
NSE:NDGL
|
IN |
|
Brii Biosciences Ltd
F:7SS
|
CN |
|
O
|
O'Reilly Automotive Inc
XMUN:OM6
|
US |
|
I
|
Icure Pharmaceutical Inc
KOSDAQ:175250
|
KR |
|
P
|
Protia Inc
KOSDAQ:303360
|
KR |
|
S
|
Sung Kwang Bend Co Ltd
KOSDAQ:014620
|
KR |
|
C
|
Cementir Holding NV
SWB:3PC
|
IT |
|
E
|
Eurofins Scientific SE
XMUN:ESF0
|
LU |
|
B
|
Brii Biosciences Ltd
DUS:7SS
|
CN |
Lumentum Holdings Inc (LU2)’s 12-month stock price forecast through November 2027 has a consensus target of €1 095.88, implying 98% upside. The forecast is based on price targets from 32 Wall Street analysts.
Past growth per year Not enough data
Average annual growth cannot be calculated for these periods.
Explore analyst estimates, growth and forecast ranges.
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
According to Wall Street analysts, the average 1-year price target for
LU2 is 1 095.88 EUR with a low forecast of 542.57 EUR and a high forecast of 1 410.14 EUR.
Over the last 13 years, the compound annual growth rate for Revenue has been 11%. The projected CAGR for the next 3 years is 66%.
Over the last 13 years, the compound annual growth rate for Gross Profit has been 14%. The projected CAGR for the next 3 years is 80%.
Over the last 13 years, the compound annual growth rate for Operating Income has been 40%. The projected CAGR for the next 3 years is 123%.
We rebuilt our DCF valuation models from the ground up and upgraded how Intrinsic Value is calculated. Alpha Spread now selects the method that best fits each company.
You can now see how the new methodology performed across thousands of stocks on our new Valuation Backtest page. We update the results at the end of every month.
By using Alpha Spread you are agreeing to our Terms of Service and Privacy Policy.
Already have an account? Sign in
Stock intrinsic value is the real worth of a company's stock, based on its financial health and performance.
Instead of looking at the stock's current market price, which can change due to people's opinions and emotions, intrinsic value helps us understand if a stock is truly a good deal or not.
By focusing on the company's actual financial strength, like its earnings and debts, we can make better decisions about which stocks to buy and when.
Read more